BDO Wealth Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4
Closed 1164
2021
Q4
$0 Hold
4
﹤0.01% 1176
2021
Q3
$0 Hold
4
﹤0.01% 1157
2021
Q2
$0 Hold
4
﹤0.01% 1236
2021
Q1
$0 Hold
4
﹤0.01% 1292
2020
Q4
$0 Sell
4
-1
-20% -$75 ﹤0.01% 1016
2020
Q3
$0 Buy
5
+1
+25% +$67 ﹤0.01% 978
2020
Q2
$0 Buy
+4
New +$220 ﹤0.01% 787

BDO Wealth Advisors's ARNA Position: Q1 2022 in Review

BDO Wealth Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 4 shares.

BDO Wealth Advisors first reported a position in ARNA in Q2 2020 and held it in 7 quarters. The position peaked at $0 in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • BDO Wealth Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • BDO Wealth Advisors sold 4 Arena Pharmaceuticals Inc shares in Q1 2022.
  • BDO Wealth Advisors first reported a position in Arena Pharmaceuticals Inc in Q2 2020 and held it in 7 quarters.
  • BDO Wealth Advisors's Arena Pharmaceuticals Inc position peaked at $0 in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on BDO Wealth Advisors's 13F filing for Q1 2022, filed 6 May 2022.